Vaxcyte stock on data for pneumococcal shot (NASDAQ:PCVX)
Kittisak Kaewchalon/iStock via Getty Images Vaccine cellNASDAQ:PCVX) stocks Added ~32% Pfizer announced Tuesday that it will market its experimental VAX-31 pneumococcal vaccine (PCV) after it showed a similar safety profile to Pfizer's…
